RU2007147368A - 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3.4-tetrahydro-1H-pyrido [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS - Google Patents
2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3.4-tetrahydro-1H-pyrido [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS Download PDFInfo
- Publication number
- RU2007147368A RU2007147368A RU2007147368/04A RU2007147368A RU2007147368A RU 2007147368 A RU2007147368 A RU 2007147368A RU 2007147368/04 A RU2007147368/04 A RU 2007147368/04A RU 2007147368 A RU2007147368 A RU 2007147368A RU 2007147368 A RU2007147368 A RU 2007147368A
- Authority
- RU
- Russia
- Prior art keywords
- receptors
- pharmaceutical composition
- neurodegenerative diseases
- treatment
- dementia
- Prior art date
Links
- KRPHBUMURAALTO-UHFFFAOYSA-N Cc1ccc(CC[n]2c3ccc(C)cc3c3c2CCN(C)C3)cc1 Chemical compound Cc1ccc(CC[n]2c3ccc(C)cc3c3c2CCN(C)C3)cc1 KRPHBUMURAALTO-UHFFFAOYSA-N 0.000 description 1
Abstract
1. Лекарственные субстанции, обладающие нейротропной активностью по отношению к α-адреноцепторам, допаминовым D и серотониновым рецепторам ЦНС, общей формулы 1 в виде свободных оснований или в виде фармацевтически приемлемых солей, предназначенных для лечения и предупреждения нейродегенеративных заболеваний и когнитивных расстройств, ! ! где R представляет собой атом водорода или низший алкил. ! 2. Лекарственные субстанции по п.1, представляющие собой 2,8-диметил-5-фенетил-1,2,3,4-тетрагидро-1Н-пиридо[4,3-b]индол 1.1, его гидрохлорид 1.2, 2,8-диметил-5-[2-(4-метилфенил)-этил]-1,2,3,4-тетрагидро-1Н-пиридо[4,3-b]индол 1.3 или его гидрохлорид 1.4. ! ! 3. Субстанции по п.1 или 2, отличающиеся тем, что спектр рецепторспецифичной агонистической и/или антагонистической активности включает активность по отношению к α1A, α1B, α1D, α2A адреноцепторам, допаминовым D1, D2L, D2S, D3, D4.2 рецепторам и серотониновым 5-НТ2А, 5-НТ2В, 5-НТ2С, 5-НТ6 и 5-НТ7 рецепторам. ! 4. Субстанции по п.1 или 2, отличающиеся тем, что спектр рецепторспецифичной агонстической и/или антагонистической активности может включать и некоторые другие рецепторы, такие как гистаминовые и имидазолиновые рецепторы, а также натриевые и кальциевые каналы и моноаминовые транспортеры. ! 5. Фармацевтическая композиция с широким спектром рецептор-специфичной активности для лечения и/или предупреждения нейродегенеративных заболеваний и когнитивных расстройств людей и теплокровных животных, содержащая фармацевтически эффективное количество субстанции формулы 1 по п.1. ! 6. Фармацевтическая композиция по п.5, содержащая фармацевтически эффективное количество лекарственной субстанции по любому из пп.2-4. ! 7. Способ п�1. Medicinal substances with neurotropic activity against α-adrenoceptors, dopamine D and central nervous system serotonin receptors, of the general formula 1 in the form of free bases or in the form of pharmaceutically acceptable salts, intended for the treatment and prevention of neurodegenerative diseases and cognitive disorders,! ! where R represents a hydrogen atom or lower alkyl. ! 2. The medicinal substances according to claim 1, which are 2,8-dimethyl-5-phenethyl-1,2,3,4-tetrahydro-1H-pyrido [4,3-b] indole 1.1, its hydrochloride 1.2, 2, 8-dimethyl-5- [2- (4-methylphenyl) ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] indole 1.3 or its hydrochloride 1.4. ! ! 3. The substances according to claim 1 or 2, characterized in that the spectrum of receptor-specific agonistic and / or antagonistic activity includes activity with respect to α1A, α1B, α1D, α2A adrenoceptors, dopamine D1, D2L, D2S, D3, D4.2 receptors and serotonin 5-HT2A, 5-HT2B, 5-HT2C, 5-HT6 and 5-HT7 receptors. ! 4. The substances according to claim 1 or 2, characterized in that the spectrum of receptor-specific agonistic and / or antagonistic activity may include some other receptors, such as histamine and imidazoline receptors, as well as sodium and calcium channels and monoamine transporters. ! 5. A pharmaceutical composition with a wide range of receptor-specific activity for the treatment and / or prevention of neurodegenerative diseases and cognitive disorders in humans and warm-blooded animals, containing a pharmaceutically effective amount of a substance of formula 1 according to claim 1. ! 6. The pharmaceutical composition according to claim 5, containing a pharmaceutically effective amount of a drug substance according to any one of claims 2 to 4. ! 7. The method of
Claims (11)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007147368/04A RU2007147368A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3.4-tetrahydro-1H-pyrido [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS |
US12/810,013 US20110039825A1 (en) | 2007-12-21 | 2008-12-19 | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use |
PCT/RU2008/000780 WO2009082268A2 (en) | 2007-12-21 | 2008-12-19 | LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
JP2010539344A JP2011507835A (en) | 2007-12-21 | 2008-12-19 | Alpha-adrenergic receptor, dopamine, histamine, imidazoline and serotonin receptor ligands and uses thereof |
EP08864305A EP2236511A4 (en) | 2007-12-21 | 2008-12-19 | Ligands of alpha-adrenoceptors and of dopamine, histamine, imidazoline and serotonin receptors and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007147368/04A RU2007147368A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3.4-tetrahydro-1H-pyrido [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008150397/04A Substitution RU2407744C2 (en) | 2008-12-19 | 2008-12-19 | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2007147368A true RU2007147368A (en) | 2009-06-27 |
Family
ID=41026637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007147368/04A RU2007147368A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3.4-tetrahydro-1H-pyrido [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2007147368A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2595809C2 (en) * | 2013-11-28 | 2016-08-27 | Мапикс Эс.Эй.Ар.Эл. | Therapeutic agent |
-
2007
- 2007-12-21 RU RU2007147368/04A patent/RU2007147368A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2595809C2 (en) * | 2013-11-28 | 2016-08-27 | Мапикс Эс.Эй.Ар.Эл. | Therapeutic agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010502722A5 (en) | ||
IL255433B2 (en) | (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine | |
CA2640223A1 (en) | Methods and compositions for treating schizophrenia | |
JP7245509B2 (en) | Fusion Benzazepines to Treat Stuttering | |
US10738018B2 (en) | Compounds for therapeutic use | |
BR112014029478A8 (en) | compounds, fluorine-containing amino acid drugs and their use | |
JP2005508381A5 (en) | ||
CA2805904A1 (en) | Use of cyclic amide derivatives to treat sigma receptor-mediated disorders | |
RU2007147368A (en) | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3.4-tetrahydro-1H-pyrido [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS | |
RU2008102155A (en) | SUBSTITUTED 3-SULFONIL- [1,2,3] TRIAZOLO [1,5-a] PYRIMIDINS-ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, MEDICINES | |
JP2004529936A5 (en) | ||
JP2005525385A5 (en) | ||
RU2008102154A (en) | SUBSTITUTED 4-SULPHONYL-PYRAZOLES AND 3-SULFONYL-PYRAZOLO [1,5-a] PYRIMIDINS-ANTAGONISTS OF SEROTONIN 5-NT6 RECEPTORS, MEDICINAL SUBSTANCE, PHARMACEOSEPHERESIS | |
WO2019220138A1 (en) | Ketamine derivatives to treat neurological or psychological diseases | |
RU2007147352A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO 1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINE SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS | |
KR102471059B1 (en) | Hydroxynorketamine derivatives for the treatment of disorders | |
RU2374245C1 (en) | Ligand with wide range of simultaneous receptor activity, pharmaceutical composition, method of preparing said composition and medicinal agent | |
ZA201005203B (en) | Chromene compounds,a process for their preparation and pharmaceutical compositions containing them | |
RU2407744C2 (en) | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and use thereof | |
RU2007147371A (en) | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3,4-TETRAHYDRO-1NPIRIDO [4,3-b] INDOLES-MEDICINE SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PRODUCTION AND APPLICATION FOR THE TREATMENT OF PSYCHOTIC DISEASES | |
JP2012504663A5 (en) | ||
NZ719103B2 (en) | Fused benzazepines for treatment of stuttering | |
RU2007147356A (en) | 2,8-DIMETHYL-5- [2-4-R-Phenyl) -ethyl] -1,2,3,4-TETRAHYDRO-1H-PYRIDO [4,3-B] LIGANDOID LIGANDES OF SEROTONIN 5-NT RECEPTORS AND THEIR APPLICATION | |
RU2010137094A (en) | METHOD, COMPOUND AND PHARMACEUTICAL COMPOSITION AND MEDICINE FOR RESTORING LOST MEMORY IN NORMAL AND PATHOLOGY | |
RU2007147351A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLES AND 1,2,3,4,5,6-HEXAHYDRO-AZEPINO [4,3-b] INDOLES-MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, WAYS OF ITS PRODUCTION AND APPLICATION FOR TREATMENT OF DISORDERS CAUSED BY CHEMICAL SUBSTANCES AND DEPENDENCE ON CHEMICAL SUBSTANCES |